...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith and Pfizer collaboration news

,,and both will share on the trial funding,,,,,,,,,,,Zenith with no $$$ and Pfizer with a market cap of over 200 Billion,,,,,,,,,,hopefully DM has the funding heavily weighted on Pfizers side!,,hopefully. Excellent news and it maybe a precursor to whats to come down the road!!,,

 

Share
New Message
Please login to post a reply